Publications by authors named "Cameron D Thomas"

Claim this Profile
I
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants.
Luis Ortega-Paz, Cameron D Thomas, Claudio Laudani, Salvatore Giordano, Francesco Franchi

Clin Pharmacol Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Phenotype, P2Y Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy.
Rajiv C Patel, Cameron D Thomas, Joseph S Rossi, Francesco Franchi, Ellen C Keeley

J Am Heart Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction.
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Julio D Duarte

Clin Pharmacol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.
Julio D Duarte, Cameron D Thomas, Craig R Lee, Rachel Huddart, Jose A G Agundez

Clin Pharmacol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies.
Larisa H Cavallari, Craig R Lee, Francesco Franchi, Ellen C Keeley, Joseph S Rossi, Cameron D Thomas

Clin Transl Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley

J Am Heart Assoc· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Clopidogrel vs Alternative P2Y Inhibitors Based on the ABCD-GENE Score.
Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson

J Am Coll Cardiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center.
Emily J Cicali, Amanda Elchynski, Cameron D Thomas, Benish Alam, Rachel Dalton

Am J Health Syst Pharm· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US.
Yehua Wang, Larisa H Cavallari, Joshua D Brown, Cameron D Thomas, Almut G Winterstein

JAMA Netw Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y Inhibitor Prescribing After Percutaneous Coronary Intervention.
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, James C Lee, Julio D Duarte, Cameron D Thomas

Clin Pharmacol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of P2Y receptor inhibitors.
Cameron D Thomas, Alexis K Williams, Craig R Lee, Larisa H Cavallari

Pharmacotherapy· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators.
Larisa H Cavallari, Emily Cicali, Kristin Wiisanen, Roger B Fillingim, Hrishikesh Chakraborty, Cameron D Thomas

Clin Transl Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation.
Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Joseph S Rossi, Marshall Winget

Clin Pharmacol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings.
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, George A Stouffer, Dominick J Angiolillo

J Am Heart Assoc· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.
Emily J Cicali, Amanda L Elchynski, Kelsey J Cook, John T Houder, Cameron D Thomas

Clin Pharmacol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
John J Lima, Cameron D Thomas, Julia Barbarino, Zeruesenay Desta, Sara L Van Driest

Clin Pharmacol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hybrid implementation-effectiveness randomized trial of CYP2D6-guided postoperative pain management.
Cameron D Thomas, Hari K Parvataneni, Chancellor F Gray, Justin T Deen, Hernan A Prieto

Genet Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Craig R Lee, Cameron D Thomas, Amber L Beitelshees, Sony Tuteja, Philip E Empey

Clin Pharmacol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores.
Cameron D Thomas, Scott A Mosley, Sarah Kim, Karthik Lingineni, Nihal El Rouby

CPT Pharmacometrics Syst Pharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic factors affecting β-blocker metabolism and response.
Cameron D Thomas, Julie A Johnson

Expert Opin Drug Metab Toxicol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the protective effects of β-blockers in the management of acute exacerbations of chronic obstructive pulmonary disease.
Cameron D Thomas, Lori H Dupree, Marci DeLosSantos, Jason A Ferreira

J Clin Pharm Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis